Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 28, 2018 02:30 ET | Source: Mendus AB

Förändring av antal aktier och röster i Immunicum AB (publ) efter genomförd riktad emission

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande 28 december 2018...
December 28, 2018 02:30 ET | Source: Mendus AB

Change in Number of Shares and Votes in Immunicum AB (publ) After Completed Directed Issue

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release 28 December 2018 Change in...
December 13, 2018 12:00 ET | Source: Mendus AB

Immunicum offentliggör utfallet i nyemissionerna - bolaget tillförs 351 MSEK

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande 13 december 2018...
December 13, 2018 12:00 ET | Source: Mendus AB

Immunicum AB (publ) Publishes the Outcome in the Share Issues and Raises SEK 351M

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release 13 December 2018 Immunicum...
November 23, 2018 05:15 ET | Source: Mendus AB

Immunicum offentliggör prospekt i samband med företrädesemission och riktad emission

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande 23 november 2018 EJ...
November 23, 2018 05:15 ET | Source: Mendus AB

Immunicum AB (publ) Publishes Prospectus in Connection with Rights Issue and Directed Issue

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release 23 November 2018 NOT...
November 16, 2018 02:30 ET | Source: Mendus AB

Immunicum tillkännager samarbete med Merck KGaA, Darmstadt, Tyskland och Pfizer för utvärdering av ilixadencel i kombination med avelumab i den planerade fas Ib/II multi-indikationsstudien ILIAD

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande 16 november 2018...
November 16, 2018 02:30 ET | Source: Mendus AB

Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release 16 November 2018...
November 08, 2018 10:30 ET | Source: Mendus AB

Kommuniké från extra bolagsstämman i Immunicum AB (publ) den 8 november 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande 8 november 2018...
November 08, 2018 10:30 ET | Source: Mendus AB

Report from Extraordinary General Meeting of Immunicum AB (publ) on 8 November 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press Release 8 November 2018 Report...